Halozyme Therape (HALO)
$62.49
1.32 (2.11%)
Halozyme Therapeutics, Inc. (HALO) Keeping Good Company
Partnerships with the likes of ABV, PFE and LLY are helping Halozyme (HALO) stock turn toward the upside.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$63.84
Market Cap
7.86B
PE Ratio
18.21
EPS
3.4314
Volume (Avg. Vol.)
1.64M
Day's Range
$62.60 - $64.07
52-Week Range
$37.73 - $66.00
Dividend & Yield
N/A (N/A)